Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
NEUTRAL SIGNAL · Alpha
██.█% Sign up free to reveal

Amarin Corp Plc\Uk (AMRN) AI Forecast

Our AI analyzed Amarin Corp Plc\Uk. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$AMRN Neutral Signal Full forecast available

Amarin Corp Plc\Uk (AMRN) Stock Forecast Sept. 24, 2026


Amarin Corp Plc\Uk (AMRN) AI Stock Price Forecast & Investment Analysis

Amarin Corp Plc\Uk Stock Price Chart and Technical Analysis

Loading chart...

Amarin Corp Plc\Uk (AMRN) - Comprehensive Stock Analysis & Investment Research

Deep dive into Amarin Corp Plc\Uk's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on September 24, 2026 (UTC)

Amarin Corp Plc\Uk Investment Summary

When evaluating whether Amarin Corp Plc\Uk (AMRN) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Amarin Corp Plc\Uk (AMRN) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $6 billion, the company is a mid-cap stock that typically offers a balance between growth potential and established business operations.

Financial Performance Analysis

Our comprehensive financial analysis covers Amarin Corp Plc\Uk's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Amarin Corp Plc\Uk along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Amarin Corp Plc\Uk is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Amarin Corp Plc\Uk

Sign Up Free
Corporate Identity

Amarin Corp Plc\Uk (Stock Symbol: AMRN) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Amarin Corp Plc\Uk's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Amarin Corp Plc\Uk...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Amarin Corp Plc\Uk...

Unlock Full Company Profile

Get complete details about Amarin Corp Plc\Uk

Sign Up Free
Revenue & Growth Analysis

Amarin Corp Plc\Uk generates annual revenues of $228 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Amarin Corp Plc\Uk...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Amarin Corp Plc\Uk...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Amarin Corp Plc\Uk...

Unlock Financial Analysis

Get complete financial metrics for Amarin Corp Plc\Uk

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Amarin Corp Plc\Uk's AI Price Forecast

Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

4537 Stocks in the out-of-sample test
73.7% Rebalance periods with a positive net return
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Amarin Corp Plc\Uk strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a mid-cap company, it occupies an attractive position balancing growth potential with established operations. Mid-caps often represent the 'sweet spot' for investors seeking companies that have proven their business models but still have meaningful runway for expansion. These companies are large enough to have competitive advantages but nimble enough to adapt quickly to market changes.

Industry Competitive Landscape

Amarin Corp Plc\Uk competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Margin & Pricing Power Analysis

The company maintains a 34.2% gross margin reflecting moderate pricing power typical of many manufacturing, retail, or service businesses. While not exceptionally high, these margins provide adequate room for operating expenses and profit generation. Competitive pressures or cost increases could impact profitability if margins compress.

Operating margin of -17.9% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Asset Utilization Efficiency

Asset turnover ratio of 0.37x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.

Financial Strength & Leverage

Current ratio of 3.67 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Amarin Corp Plc\Uk (AMRN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Amarin Corp Plc\Uk stock analysis.

Deep dive into Amarin Corp Plc\Uk's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Amarin Corp Plc\Uk stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Amarin Corp Plc\Uk:

P/B Ratio 12.72x
Market Cap $5.64B
EPS $-0.08
Book Value/Share $1.06
Revenue/Share $0.54
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Amarin Corp Plc\Uk converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Amarin Corp Plc\Uk: An ROE of -6.1% indicates room for improvement in shareholder value creation.

ROE -6.1%
ROA -4.3%
ROIC -8.9%
Gross Margin 34.2%
Operating Margin -17.9%
Net Margin -11.9%
EBT Margin -11.2%
Tax Rate -6.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Amarin Corp Plc\Uk's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Amarin Corp Plc\Uk: A current ratio of 3.67 indicates strong liquidity.

Current Ratio 3.67x
Quick Ratio 2.67x
D/E Ratio 0.41x
Financial Leverage 1.41x
Interest Coverage -903.9x
Working Capital $439M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Amarin Corp Plc\Uk's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Amarin Corp Plc\Uk:

Operating Cash Flow $16M
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Amarin Corp Plc\Uk uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Amarin Corp Plc\Uk: An asset turnover of 0.37x suggests room for improvement in asset utilization.

Asset Turnover 0.37x
Receivables Turnover 2.5x
Days Sales Outstanding 149 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Amarin Corp Plc\Uk's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Amarin Corp Plc\Uk: With annual revenue of $228M, Amarin Corp Plc\Uk demonstrates solid business size.

Income Statement
Total Revenue $228M
Operating Income -$40M
Net Income -$27M
R&D Expense $19M
SG&A Expense $83M
Balance Sheet Highlights (USD millions)
Total Current Assets $603M (96.6% of assets)
Cash & Short-term Investments $144M (23.0% of assets)
Accounts Receivable $93M (14.9% of assets)
Inventory $164M (26.3% of assets)
Total Liabilities $181M (29.0% of assets)
Short-term Debt $145M (23.3% of assets)
Dividend & Shareholder Information
Shares Outstanding 420M

Latest Amarin Corp Plc\Uk Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Amarin Corp Plc\Uk (AMRN) stock price and investment outlook.

📰 Loading...

Where AMRN sits on the market map

Explore the map →

Amarin Corp Plc\Uk Industry Peers - Pharmaceutical Preparations

Companies classified under the same SEC industry code as Amarin Corp Plc\Uk (Pharmaceutical Preparations): 60 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Company Ticker Symbol 90-Day AI Forecast (Alpha) Market Cap (USD M) P/E Ratio P/B Ratio
AMRN ██% $5.64B x 12.7x
LLY ██% $1.08T 40.6x 110.2x
JNJ ██% $648.67B 30.8x 7.6x
ONC ██% $539.52B x 104.3x
ABBV ██% $468.43B 74.2x x
MRK ██% $365.34B 115.1x 8.7x
NVS ██% $272.31B x x
GSK ██% $214.26B x x
ABT ██% $180.26B 28.6x 3.5x
PFE ██% $160.62B 37.1x 1.9x
VRTX ██% $130.87B 29.7x 6.5x
BMY ██% $125.63B 13.5x 5.6x
REGN ██% $82.55B 19.1x 2.6x
SNY ██% $50.80B x x
TEVA ██% $45.46B 64.3x 5.9x
ALNY ██% $33.40B x 24.7x
RPRX ██% $33.15B 40.7x 4.9x
ATHE ██% $32.40B x x
TAK ██% $29.93B x x
ZLAB ██% $29.68B x 48.9x
ZTS ██% $29.59B 11.3x 9.4x
ROIV ██% $26.60B x 6.3x
INSM ██% $25.84B x 34.1x
UTHR ██% $20.99B 16.0x 3.3x
VTRS ██% $19.66B x x
JAZZ ██% $15.25B 16.2x 3.2x
ASND ██% $14.30B x x
SMMT ██% $13.12B x 20.8x
BBIO ██% $12.96B x x
CORT ██% $12.81B x 18.2x
HCM ██% $12.54B x 10.1x
BMRN ██% $11.88B x 1.9x
KNSA ██% $11.87B x 19.6x
MDGL ██% $11.85B x 22.6x
ELAN ██% $11.17B x 1.7x
RDY ██% $10.34B x x
AXSM ██% $10.27B x 123.3x
ARWR ██% $9.33B x 20.1x
CYTK ██% $9.13B x x
PTGX ██% $8.98B x 10.7x
PRAX ██% $7.88B x 5.9x
SYRE ██% $7.77B x 7.1x
GPCR ██% $7.71B x 5.7x
ABVX ██% $7.39B x x
IONS ██% $7.30B x 16.6x
ALKS ██% $6.84B x 3.8x
LEGN ██% $6.82B x x
RYTM ██% $6.76B x 65.7x
BLRX ██% $6.68B x x
BLTE ██% $6.67B x 8.7x
AMRX ██% $6.32B x x
LQDA ██% $6.04B x 31.0x
LGND ██% $5.95B 30.2x 6.2x
MIRM ██% $5.80B x x
TVTX ██% $5.64B x 230.0x
COGT ██% $5.45B x 10.2x
PTCT ██% $5.20B x x
ERAS ██% $5.08B x 14.0x
DNTH ██% $5.07B x 4.3x
VKTX ██% $4.86B x 11.9x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Amarin Corp Plc\Uk Stock Forecast

How accurate are Amarin Corp Plc\Uk stock predictions?

A per-ticker accuracy statistic for AMRN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

What factors influence Amarin Corp Plc\Uk stock price forecasts?

Our analysis considers Amarin Corp Plc\Uk's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Amarin Corp Plc\Uk a good investment in 2026?

Based on our AI analysis, Amarin Corp Plc\Uk shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Amarin Corp Plc\Uk forecasts updated?

Amarin Corp Plc\Uk forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on September 24, 2026.

Want a simpler view of Amarin Corp Plc\Uk?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...